Literature DB >> 19663690

Epidemiology of dermatitis and skin infections in United States physicians' offices, 1993-2005.

Daniel J Pallin1, Janice A Espinola, Donald Y Leung, David C Hooper, Carlos A Camargo.   

Abstract

BACKGROUND: Since the discovery of community-associated methicillin-resistant Staphylococcus aureus (MRSA), the number of emergency department visits for skin and soft-tissue infection (SSTI) has increased, and one report suggested an increase in the much larger setting of physicians' offices. Dermatitis compromises the cutaneous barrier to microorganisms and may predispose to SSTI. Our objectives were to determine whether office visits for dermatitis or SSTI have become more frequent since the emergence of community-associated MRSA, to describe the age-specific frequency of visits for dermatitis and SSTI, and to determine whether dermatitis is associated with SSTI and whether the association strengthened over time.
METHODS: We analyzed visits for the diagnoses of dermatitis and SSTI by means of codes from the International Classification of Diseases, Ninth Revision recorded in the National Ambulatory Medical Care Survey, 1993-2005. We calculated population estimates by year and age group, with 95% confidence intervals (CIs), and examined trends over time. Multivariate logistic regression quantified the association between dermatitis and SSTI and assessed for interaction between dermatitis and year in the prediction of SSTI.
RESULTS: Dermatitis was diagnosed at 13 million office visits per year (95% CI, 12-14 million office visits per year) over the study period, and SSTI was diagnosed at 6.3 million office visits per year (95% CI, 5.8 million-6.8 million office visits per year). The frequency did not change for either diagnosis over time when expressed as a percentage of all visits (both, p < .60). Dermatitis was most common among infants (256 visits per 1,000 population per year; 95% CI, 216-293 visits per 1,000 population per year). The rate of diagnosis of SSTI did not vary importantly by age. Dermatitis was associated with SSTI (odds ratio, 2.54; 95% CI, 1.92-3.35). The association did not strengthen over time.
CONCLUSIONS: The rate of office visits for dermatitis or SSTI did not increase from 1993 through 2005. Dermatitis was associated with SSTI. This association did not strengthen as community-associated MRSA became prevalent.

Entities:  

Mesh:

Year:  2009        PMID: 19663690     DOI: 10.1086/605434

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

Review 1.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Anti-pollution cosmetic-based one-step formation of w/o/w multiple emulsion containing D-biotin for skin protection: fabrication and in vitro and in vivo evaluation.

Authors:  Atif Ali; Sajid Iqbal; Aqsa Ilyas; Hira Khan; Muhammad Hassham Hassan Bin Asad; Nighat Fatima; Naveed Akhtar
Journal:  Drug Deliv Transl Res       Date:  2019-12       Impact factor: 4.617

3.  Outpatient management of moderate cellulitis in children using high-dose oral cephalexin.

Authors:  Evelyne D Trottier; Beatrice Farley St-Amand; Mélanie Vincent; Isabelle Chevalier; Julie Autmizguine; Stéphanie Tremblay; Serge Gouin
Journal:  Paediatr Child Health       Date:  2022-05-03       Impact factor: 2.600

4.  High-density livestock operations, crop field application of manure, and risk of community-associated methicillin-resistant Staphylococcus aureus infection in Pennsylvania.

Authors:  Joan A Casey; Frank C Curriero; Sara E Cosgrove; Keeve E Nachman; Brian S Schwartz
Journal:  JAMA Intern Med       Date:  2013-11-25       Impact factor: 21.873

5.  Allergen immunotherapy: No evidence of infectious risk.

Authors:  Diana S Balekian; Aleena Banerji; Kimberly G Blumenthal; Carlos A Camargo; Aidan A Long
Journal:  J Allergy Clin Immunol       Date:  2016-04-09       Impact factor: 10.793

6.  Ceftobiprole Activity against Bacteria from Skin and Skin Structure Infections in the United States from 2016 through 2018.

Authors:  Robert K Flamm; Leonard R Duncan; Kamal A Hamed; Jennifer I Smart; Rodrigo E Mendes; Michael A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

7.  Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Skin Structure Infections.

Authors:  Kenneth LaPensee; Rohit Mistry; Thomas Lodise
Journal:  Am Health Drug Benefits       Date:  2019-02

Review 8.  Implications of Antibiotic Resistance for Patients' Recovery From Common Infections in the Community: A Systematic Review and Meta-analysis.

Authors:  Oliver van Hecke; Kay Wang; Joseph J Lee; Nia W Roberts; Chris C Butler
Journal:  Clin Infect Dis       Date:  2017-08-01       Impact factor: 9.079

Review 9.  New developments in the management of severe skin and deep skin structure infections - focus on tedizolid.

Authors:  Michael J Durkin; G Ralph Corey
Journal:  Ther Clin Risk Manag       Date:  2015-05-22       Impact factor: 2.423

10.  Use of electronic health record data to identify skin and soft tissue infections in primary care settings: a validation study.

Authors:  Pamela J Levine; Miriam R Elman; Ravina Kullar; John M Townes; David T Bearden; Rowena Vilches-Tran; Ian McClellan; Jessina C McGregor
Journal:  BMC Infect Dis       Date:  2013-04-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.